پیوندهای مفید
آمار
| تعداد نشریات | 20 |
| تعداد شماره‌ها | 1,089 |
| تعداد مقالات | 9,995 |
| تعداد مشاهده مقاله | 26,278,303 |
| تعداد دریافت فایل اصل مقاله | 7,264,095 |
Case Report of China/Tianjin's First Novel Coronavirus Variant Omicron | ||
| Iranian Journal of Immunology | ||
| دوره 19، شماره 1، خرداد 2022، صفحه 115-120 اصل مقاله (778.55 K) | ||
| نوع مقاله: Case Report | ||
| شناسه دیجیتال (DOI): 10.22034/iji.2022.94050.2278 | ||
| نویسندگان | ||
| Haibai Sun؛ Hongjie Li؛ Shuping Huang؛ Lixia Shi؛ Zhiyan Xing؛ Jun Shen* | ||
| Tianjin Institute of Respiratory Diseases, Tianjin Haihe Hospital, 890 Jingu Road, Shuanggang Town, Jinnan District, Tianjin, China. | ||
| چکیده | ||
| COVID-19 is a new acute respiratory infectious disease caused by a novel Coronavirus (2019-COV-2) infection. On November 26, 2021, the World Health Organization announced a new 2019-COV-2 variant strain Omicron (B.1.1.529). Omicron's emergence added further uncertainty to the outbreak. Here we report the first case infected with Omicron in China, a 17-year-old female student. In this paper, the clinical symptoms, laboratory and imaging examinations and treatment of the first Omicron-infected patient in China were analyzed. This report might provide a reference for the diagnosis and treatment of patients infected with Omicron strain across the world. The novel Coronavirus antibody tests were performed on the day of admission: IgM level was normal, novel Coronavirus antibody IgG was 132.666s /CO and IgG was 148.47s /CO on the 7th day of admission. IgG showed an increasing trend, which is consistent with the results of multiple novel Coronavirus non-Omicron strain infections. | ||
| کلیدواژه‌ها | ||
| COVID-19؛ Examination؛ Laboratory Omicron Variant؛ SARS-CoV-2 | ||
|
آمار تعداد مشاهده مقاله: 1,072 تعداد دریافت فایل اصل مقاله: 898 |
||